Amphastar Pharmaceuticals Inc Revenue per Employee (AMPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amphastar Pharmaceuticals Inc   (NASDAQ: AMPH)
 

Amphastar Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.22% in the third quarter 2026, year on year to cumulative value of $746 million, Amphastar Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 377,423. The productivity of Amphastar Pharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 265 other companies have achieved higher revenue per employee. While Amphastar Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 1949 to 2152. Amphastar Pharmaceuticals Inc has 1,976 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMPH Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 8.22 % 5.44 % 0.38 % -2.79 % 0.33 %
Sales per Employee (TTM) $ 377,423 369,443 364,641 364,315 366,975
AMPH's Total Ranking # 2152 # 1949 # 1591 # 1586 #
Seq. Revenue Change 12.89 % 7.44 % -6.52 % -4.55 % 9.99 %

AMPH Company Profile >> Back to AMPH Efficiency Comparisons >> Compare AMPH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 128
Healthcare Sector # 266
Overall Market # 2152

Revenue per Employee Statistics
High Average Low
$ 371,359 $ 216,439 $ 112,084
(Dec 31 2024)   (Mar 31 2015)



Financial Statements
Amphastar Pharmaceuticals Inc 's Revenue MRQ $ 208 Millions Visit AMPH's Income Statement
Amphastar Pharmaceuticals Inc 's Revenues TTM $ 746 Millions Visit AMPH's aggregate revenue growth
What are AMPH's Sales? Visit AMPH's Sales by Segment




Other Ratios
Amphastar Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AMPH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AMPH's Competitors
Revenue per Employee for AMPH's Suppliers
Revenue per Employee for AMPH's Customers

You may also want to know
AMPH's Sales Growth Rates AMPH's Pe Price to earnings ratio AMPH's Receivables Turnover Ratio AMPH's Stock Quote
AMPH's Net Income Growth Rates AMPH's Ps Price to Sales ratio AMPH's Sales per Employee AMPH's Asset Turnover Ratio
AMPH's Net Margin AMPH's Pb Price to Book ratio AMPH's Financial Strength Ratios AMPH's Dividend Payout Ratio
Date modified: 2026-11-06T12:56:49+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.